Impaired Rivaroxaban Clearance in Mild Renal Insufficiency With Verapamil Coadministration: Potential Implications for Bleeding Risk and Dose Selection
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impaired Rivaroxaban Clearance in Mild Renal Insufficiency With Verapamil Coadministration: Potential Implications for Bleeding Risk and Dose Selection
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL PHARMACOLOGY
Volume 58, Issue 4, Pages 533-540
Publisher
Wiley
Online
2017-12-01
DOI
10.1002/jcph.1040
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Laboratory Monitoring of Non–Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation
- (2017) John W. Eikelboom et al. JAMA Cardiology
- Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation
- (2016) Anna Plitt et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Pharmacology of anticoagulants used in the treatment of venous thromboembolism
- (2016) Edith A. Nutescu et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Rivaroxaban for the treatment and prevention of thromboembolic disease
- (2015) Sotiris Antoniou JOURNAL OF PHARMACY AND PHARMACOLOGY
- Pharmacology of antithrombotic drugs: an assessment of oral antiplatelet and anticoagulant treatments
- (2015) Jessica L Mega et al. LANCET
- An open-label study to estimate the effect of steady-state erythromycin on the pharmacokinetics, pharmacodynamics, and safety of a single dose of rivaroxaban in subjects with renal impairment and normal renal function
- (2014) Kenneth T. Moore et al. JOURNAL OF CLINICAL PHARMACOLOGY
- New oral anticoagulants in patients with nonvalvular atrial fibrillation: a review of pharmacokinetics, safety, efficacy, quality of life, and cost effectiveness
- (2014) Helen Mani et al. Drug Design Development and Therapy
- Co-administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects
- (2013) Wolfgang Mueck et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban
- (2013) Wolfgang Mueck et al. CLINICAL PHARMACOKINETICS
- New Oral Anticoagulants: Comparative Pharmacology with Vitamin K Antagonists
- (2013) Francesco Scaglione CLINICAL PHARMACOKINETICS
- The Influence of Age and Gender on the Pharmacokinetics and Pharmacodynamics of Rivaroxaban-An Oral, Direct Factor Xa Inhibitor
- (2013) Dagmar Kubitza et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Oral direct factor Xa inhibitors for stroke prevention in atrial fibrillation
- (2012) Katherine P. Cabral et al. Nature Reviews Cardiology
- Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor
- (2010) Dagmar Kubitza et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Metabolism and Excretion of Rivaroxaban, an Oral, Direct Factor Xa Inhibitor, in Rats, Dogs, and Humans
- (2009) C. Weinz et al. DRUG METABOLISM AND DISPOSITION
- In Vitro Metabolism of Rivaroxaban, an Oral, Direct Factor Xa Inhibitor, in Liver Microsomes and Hepatocytes of Rats, Dogs, and Humans
- (2009) D. Lang et al. DRUG METABOLISM AND DISPOSITION
- Drugs Behave as Substrates, Inhibitors and Inducers of Human Cytochrome P450 3A4
- (2008) Shu-Feng Zhou CURRENT DRUG METABOLISM
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started